Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Number of contacts with the health-care before and after starting insulin treatment

From: Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice

 

Diabetes-related contacts

Diabetes-related contacts including cardiovascular

Other contacts

 

Pre-index

Post-index

Pre-index

Post-index

Pre-index

Post-index

Treatment

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

NPH

2.0 ± 1.8

2.7 ± 2.8

2.2 ± 2.4

3.1 ± 3.7

11.8 ± 15.4

13.9 ± 16.1

IG

2.1 ± 2.4

2.6 ± 3.1

2.3 ± 2.7

2.9 ± 3.3

12.6 ± 14.7

15.0 ± 16.2

ID

1.9 ± 2.1

2.4 ± 2.4

2.1 ± 2.4

2.6 ± 2.6

12.0 ± 13.8

14.2 ± 16.0

PM

2.1 ± 1.9

2.6 ± 2.5

2.4 ± 2.3

3.0 ± 3.3

13.1 ± 15.5

14.8 ± 15.5

p-values

0.003

0.044

0.00004

0.022

0.00002

0.0009

  1. NPH Neutral protamine Hagedorn, IG insulin glargine, ID insulin determir, PM premixed insulin, SD standard deviation
Back to article page

Cardiovascular Diabetology – Endocrinology Reports

ISSN: 3059-4057

Contact us